AstraZeneca

Open: 65.33 Close: 64.85 Change: -0.48

You don't have read the whole internet to decide whether to invest in AstraZeneca. Use an AI.

How much time have you spent trying to decide whether investing in AstraZeneca? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, company, …

Concept Map

Semantic Network

Stock Summary

AstraZeneca PLC focuses on the discovery, development, manufacture, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa,.

Today's Summary

Astrazeneca PLC (AZN) closed at $64.85 in the latest trading session, marking a -0.86% move from the prior day. The average price target for AstraZeneca is $79.00, which is 21.82% higher than the current price.

Today's News

AstraZeneca has been listed among the top 100 Best Companies by Working Mother magazine. For the 14th consecutive year, AstraZecas has been ranked 11 in Working Mothers list. AstraZeneca is not responsible for the privacy policy of any third party websites. The company is one of several pharmaceutical companies participating in a prescription drug discount program. AstraZeneca shares drop as lung cancer trial update lags expectations. At 0855 GMT, shares in Astra Zeneca were down 5.8% at their lowest level in more than three months. Astrazeneca PLC (AZN) closed at $64.85 in the latest trading session, marking a -0.86% move from the prior day. The average price target for AstraZeneca is $79.00, which is 21.82% higher than the current price. Astrazenecas New-York listed ADR rose 2.6% before the open Wednesday. AstraZeneca shares slump after Phase 3 lung cancer drug study. Datopotamab deruxtecan shown to prolong progression-free survival compared with standard chemotherapy in patients whose non-small cell lung cancer had returned after one or two prior treatment attempts. AstraZeneca paid $85 million upfront to Quell Therapeutics to develop Treg therapies for Type 1 diabetes and inflammatory bowel disorder. The company added an indication to Lynparzas label for the treatment of adults with prostate cancer. AstraZeneca is currently classified as a High Flyer. The analyst consensus target price for shares is 12,307.57p. That is 21.74% above the last closing price of 10,110.00p. AstraZeneca plc set to release earnings on 7/28/2023. Over the last 12 months, the company has reported EPS of $1.64. The announcement came on July 6, 2023, at the same time as the launch of the AstraZeca Brazil Health Innovation Hub. Astrazeneca drops bcma drug after seeing early clinical data. AstraZeneca launches asthma awareness campaigns for physicians and patients.

Stock Profile

"AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom."

Keywords

Are looking for the most relevant information about AstraZeneca? Investor spend a lot of time searching for information to make investment decisions in AstraZeneca. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, company, share, cancer, price, list, drug, and the most common words in the summary are: astrazeneca, stock, news, submit, market, price, business, . One of the sentences in the summary was: The average price target for AstraZeneca is $79.00, which is 21.82% higher than the current price.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #astrazeneca #stock #news #submit #market #price #business.